Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 162fludarabine phosphate 127Mycophenolic Acid 96Tacrolimus 92Whole-Body Irradiation 85Busulfan 85Peripheral Blood Stem Cell Transplantation 82fludarabine 79Cyclosporine 68Melphalan 63Antilymphocyte Serum 58Filgrastim 56Methotrexate 55Thiotepa 39Radiotherapy 39Cord Blood Stem Cell Transplantation 34Granulocyte Colony-Stimulating Factor 29Cytarabine 28Methylprednisolone 27Stem Cell Transplantation 26Sirolimus 24thymoglobulin 23Etoposide 23Clofarabine 22Rituximab 19Flow Cytometry 15Cyclosporins 15sargramostim 13Specimen Handling 13Alemtuzumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × domatinostat × Myeloid × Clear all
NCT01344707 2015-04-01

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

4SC AG

Phase 1 Completed
36 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡